Other languages Exicure, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-19 pm EDT			5-day change	1st Jan Change
0.561 ^USD	-3.08%		-3.28%	-3.33%

Mar. 22	North American Morning Briefing : Stocks Struggle After New Records	DJ
Feb. 29	An unknown buyer agreed to acquire 39.3% stake in Exicure, Inc. from DGP Co.,Ltd. for KRW 6 billion.	CI

Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis	Feb. 05
Wall Street Set to Open Lower Friday; Employment Growth Tops Forecasts	Dec. 08
Investors Look Ahead to Economic Indicators as US Futures Trend Lower in Friday's Premarket	Dec. 08
Top Premarket Gainers	Dec. 08
Northwestern University Notifies Exicure, Inc. that it Was Terminating the 2014 License	23-10-06
Exicure, Inc. Appoints Minhee Eom to the Board	23-09-27
Exicure Appoints New CEO, CFO	23-08-23
Exicure, Inc. Announces Executive Changes	23-08-23
Exicure, Inc. Announces Executive Changes	23-08-23
Exicure Inc Provides Information to Shareholders	23-08-23
Exicure, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11
CBI Co Provides Information to Shareholders of Exicure Inc	23-08-08
Exicure, Inc. Announces Resignation of Cheolho Jo from the Board and the Audit Committee	23-08-04
Exicure, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-07-14
Exicure, Inc. Appoints Jung Sang Kim as Chief Executive Officer	23-05-29
Exicure, Inc. Appoints Jung Sang Kim as Class II Director	23-05-29
Exicure Says Board Fully Backs CEO in Exploration of Strategic Alternatives	23-05-26
CBI USA Inc Sends a Letter to Exicure Inc	23-05-17
Exicure, Inc. Announces Board Changes	23-04-28
Exicure, Inc. Announces CEO Changes	23-04-28

No results for this search